DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Small Molecule Drugs cited in Vanda Pharmaceuticals Inc. v. Apotex Inc.
|Date Filed||Document No.||Description||Snippet||Link To Document|
|2019-12-30||1||Complaint||or more claims of Vanda’s U.S. Patent No. 10,376,487 (“the ’487 patent”), which, in relevant part, generally… V. THE PATENT-IN-SUIT (U.S. PATENT NO. 10,376,487) … ’487 patent, entitled “Method of Treatment.” The USPTO duly and legally issued the ’487 patent on August…’487 patent is attached to this Complaint as Exhibit A. 32. The ’487 patent generally…is covered by the ’487 patent, and Vanda has the right to enforce the ’487 patent and sue for infringement||External link to document|
|2019-12-30||4||Patent/Trademark Report to Commissioner of Patents||the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,376,487. (lak) (Entered: 12…30 December 2019 1:19-cv-02375 835 Patent - Abbreviated New Drug Application(ANDA) None||External link to document|
|>Date Filed||>Document No.||>Description||>Snippet||>Link To Document|